ORIC Similar Chart Price Prediction
The price of ORIC is predicted to go up 10.35%, based on the high correlation periods with MHK. The similarity of these two price pattern on the periods is 97.13%.
ORIC
MHK
Up: 10.35%Similarity: 97.13%
ORIC Revenue Forecast
ORIC EPS Forecast
ORIC FAQs
What is ORIC eps forecast for next quarter？
ORIC Analyst's Forecast
Soumit Roy
Jones Trading
Strong Buy
2024-10-31
Price Target
$17
Upside
+81.24%
JonesResearch initiated coverage of Oric Pharmaceuticals with a Buy rating and $17 price target. Oric is focused on developing clinical stage targeted therapeutics to overcome resistance in genetically defined lung cancer and in broad metastatic prostate cancer patients, the analyst tells investors in a research note. The firm sees "see clear signs of differentiation with specificity, breadth of mutation coverage and safety profile."
